M. Blaney

发表

Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002.

H. Krumholz, R. McNamara, J. Herrin, 2006, Journal of the American College of Cardiology.

Improvement of Hemodialysis Catheter Function with Tenecteplase: A Phase III, Open-Label Study: TROPICS 4

M. Blaney, J. Wetmore, M. Oliver, 2010, Journal of Thrombosis and Thrombolysis.

Acute reperfusion therapy in ST-elevation myocardial infarction from 1994-2003.

H. Krumholz, M. Blaney, B. Nallamothu, 2007, The American journal of medicine.

Clinical Characteristics of Dialysis Patients With Acute Myocardial Infarction in the United States: A Collaborative Project of the United States Renal Data System and the National Registry of Myocardial Infarction

M. Blaney, C. Herzog, Cheryl Arko, 2007, Circulation.

A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 3.

M. Blaney, J. Tumlin, D. Spiegel, 2010, Clinical journal of the American Society of Nephrology : CJASN.

A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer

P. LoRusso, M. Blaney, H. Burris, 2017, Clinical Cancer Research.

Results from a phase 2 study of enzalutamide (ENZA), an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC).

C. Hudis, M. Blaney, I. C. Tudor, 2015 .

Efficacy and safety of dilpacimab (ABT-165) versus bevacizumab plus FOLFIRI in metastatic colorectal cancer: a phase II study.

M. Blaney, Z. Wainberg, L. Naumovski, 2022, Future oncology.

Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction.

Harlan M Krumholz, Elizabeth H Bradley, Jeph Herrin, 2006, Journal of the American College of Cardiology.

Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction.

H. Krumholz, R. McNamara, J. Herrin, 2005, JAMA.

1802 Overall survival (OS) from the phase 2 study of enzalutamide (ENZA), an androgen receptor (AR) signaling inhibitor, in AR+ advanced triple-negative breast cancer (aTNBC)

C. Hudis, M. Blaney, I. C. Tudor, 2015 .

Thermal Camera detection of High Temperature for mass COVID Screening

M. Blaney, D. Lowe, J. Thomson, 2021, medRxiv.

Alteplase for the treatment of central venous catheter occlusion in children: results of a prospective, open-label, single-arm study (The Cathflo Activase Pediatric Study).

M. Blaney, B. Jacobs, J. Kerner, 2006, Journal of vascular and interventional radiology : JVIR.

Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction.

Harlan M Krumholz, Elizabeth H Bradley, Jeph Herrin, 2004, JAMA.

TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters.

M. Blaney, N. Gabrail, E. Sandler, 2010, Journal of vascular and interventional radiology : JVIR.

A phase III, open-label, single-arm study of tenecteplase for restoration of function in dysfunctional central venous catheters.

M. Blaney, R. Shulman, B. Jacobs, 2011, Journal of vascular and interventional radiology : JVIR.

Tenecteplase for the improvement of blood flow rate in dysfunctional hemodialysis catheters.

M. Blaney, M. Oliver, S. Fishbane, 2010, Clinical nephrology.

The pre-hospital electrocardiogram and time to reperfusion in patients with acute myocardial infarction, 2000-2002: findings from the National Registry of Myocardial Infarction-4.

Harlan M Krumholz, Elizabeth H Bradley, Jeph Herrin, 2006, Journal of the American College of Cardiology.

Early Coronary Revascularization Diminishes the Risk of Ischemic Stroke With Acute Myocardial Infarction

S. Steinhubl, M. Blaney, E. Shry, 2006, Stroke.

Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction.

H. Krumholz, R. McNamara, S. Rathore, 2007, The American journal of cardiology.

Achieving door-to-balloon times that meet quality guidelines: how do successful hospitals do it?

Harlan M Krumholz, Elizabeth H Bradley, Eric S Holmboe, 2005, Journal of the American College of Cardiology.

Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors

G. Sledge, J. Nemunaitis, M. Blaney, 2021, Molecular Cancer Therapeutics.

10PA PHASE 1 OPEN-LABEL STUDY EVALUATING THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF ENZALUTAMIDE ALONE OR COMBINED WITH AN AROMATASE INHIBITOR IN WOMEN WITH ADVANCED BREAST CANCER

C. Hudis, P. LoRusso, M. Blaney, 2014 .

Door-to-drug and door-to-balloon times: where can we improve? Time to reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI).

Harlan M Krumholz, Elizabeth H Bradley, Jeph Herrin, 2006, American heart journal.

975TiP Phase Ib trial of ABBV-368 + tilsotolimod in combination with nab-paclitaxel and/or budigalimab (ABBV-181) in patients with recurrent/metastatic head and neck squamous cell carcinoma

J. Berlin, M. Blaney, J. Grewal, 2020 .

Safety, tolerability, and pharmacokinetics of the OX40 agonist ABBV-368 in patients with advanced solid tumors.

A. Tolcher, M. Blaney, A. Patnaik, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors

G. Sledge, J. Nemunaitis, M. Blaney, 2021, Molecular Cancer Therapeutics.

ABT-165 plus FOLFIRI vs bevacizumab (bev) plus FOLFIRI in patients (pts) with metastatic colorectal cancer (mCRC) previously treated with fluoropyrimidine/oxaliplatin and bev.

M. Blaney, Z. Wainberg, L. Naumovski, 2018 .